Clinical Trials Browser

Phase 1 × INDUSTRY × oblimersen × Clear all

NCT00636545 2012-04-06

Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00409383 2011-11-07

Abraxane and Temodar Plus Genasense in Advanced Melanoma

Phase 1 Unknown

Melanoma

NCT00543231 2007-10-12

A Phase I Study of G3139 Subcutaneous in Solid Tumors

Phase 1 Completed

Neoplasms